Arteris and Everspin Technologies both operate in the semiconductor ecosystem, but they serve different layers of the technology stack. Arteris supplies network-on-chip (NoC) interconnect intellectual property (IP) that helps engineers connect components inside complex AI and chiplet-based processors, while Everspin designs and manufactures magnetoresistive random-access memory (MRAM), a non-volatile memory used in industrial, medical, aerospace, and data-center systems. Both names have delivered strong revenue growth in recent quarters and both have pulled back sharply from earlier 52-week highs, making this stock comparison timely for investors weighing AI-driven design growth against a specialized, hardware-centric memory business.
Arteris, Inc. is a Campbell, California-based provider of semiconductor interconnect IP and design tools. Its network-on-chip technology coordinates on-chip data movement in increasingly complex processors, a role that has gained relevance as AI accelerators and multi-die "chiplet" designs multiply. In its most recent quarter, Arteris reported revenue of $25.8 million, up 48% year over year, with a narrowed non-GAAP operating loss and raised full-year revenue guidance. Management cited record contracted backlog — including remaining performance obligations above $135 million — and the milestone of surpassing 1,000 customer design starts. Despite strong fundamentals, the stock has retreated substantially from its 52-week high, reflecting profit-taking and valuation concerns around a company that remains loss-making on a GAAP (Generally Accepted Accounting Principles) basis. Recent weeks have shown consolidation in the high-teens price range.
Everspin Technologies is the world's leading commercial developer of MRAM, a persistent memory that retains data without power, which suits mission-critical applications. Headquartered in Chandler, Arizona, the company operates a fabrication facility and sells into industrial automation, data center, medical, automotive, and aerospace markets. In its latest quarter, Everspin posted record revenue of $20.6 million, up 47% year over year, with non-GAAP net income of $0.12 per share and gross margin above 50%. Growth was driven by industrial automation recovery, data-center demand, and a $40 million subcontract with a U.S. prime contractor, alongside a foundry agreement with Microchip and a partnership with Teledyne HiRel. However, litigation and regulatory costs — including a provision tied to export-control matters — continue to weigh on GAAP results, and the company filed a $100 million mixed shelf offering in recent weeks. The stock has experienced notable volatility, trading well below its 52-week high.
Tickeron maintains a large library of AI trading bots covering thousands of tickers, but only a curated subset earns a place on the Trending AI Robots page. This section highlights the bots best suited to current market conditions rather than the full catalog. The available bots span different trading styles, strategies, timeframes, performance records, and sets of tickers, giving traders a range of approaches for momentum, swing, and longer-horizon setups. By focusing on the most relevant and timely strategies, the Trending AI Robots section helps investors identify tools aligned with today's market environment. Traders comparing names like Arteris and Everspin can explore Trending AI Robots to see which automated strategies are currently being favored.
The clearest contrast between these two stocks lies in their business models. Arteris is an asset-light IP licensing and royalty business with an 87% gross margin and a recurring royalty stream that is still ramping, positioning it as a high-multiple, growth-oriented play on AI and chiplet adoption. Everspin is a capital-intensive chip manufacturer whose economics depend on fabrication capacity, product mix, and manufacturing costs, with gross margins above 50% and non-GAAP profitability already in place. On growth drivers, Arteris leans on design wins converting into future royalties, while Everspin leans on near-term shipments and government-linked contracts. Risk profiles also differ: Arteris faces dilution from stock-based compensation and GAAP losses, while Everspin contends with litigation, regulatory fines, a shelf offering, and a beta near 2.1, indicating higher market sensitivity. On market sentiment, both stocks have cooled after speculative run-ups, but Arteris retains a larger market capitalization and a steadier trend following its earnings beat-and-raise.
Based on observable factors, Tickeron's AI would likely favor AIP over MRAM in the current environment. Arteris combines a debt-free balance sheet, a record contracted backlog, raised guidance, and a clear, recurring royalty catalyst tied to AI and chiplet designs — factors that support more consistent trend behavior and relative positioning. Everspin's momentum and non-GAAP profitability are notable, but its higher volatility, litigation and regulatory overhangs, and capital-intensive model introduce greater uncertainty. This assessment reflects a probabilistic reading of current data rather than a definitive forecast, and conditions can shift as new earnings and market data emerge.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AIP saw its Momentum Indicator move below the 0 level on November 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 77 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 62 cases where AIP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for AIP turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 46 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AIP entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AIP's RSI Oscillator exited the oversold zone, 26 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
Following a +1.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIP advanced for three days, in 243 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
AIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AIP's P/B Ratio (12.928) is slightly higher than the industry average of (5.443). P/E Ratio (-20.460) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (11.062) is also within normal values, averaging (45.795).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
MRAM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRAM as a result. In 64 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The 50-day moving average for MRAM moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for MRAM entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for MRAM's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +20.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRAM advanced for three days, in 222 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
MRAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.910) is normal, around the industry mean (5.443). P/E Ratio (-97.833) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (5.328) is also within normal values, averaging (45.795).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. MRAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MRAM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 93 | |
SMR RATING 1..100 | 92 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 98 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AIP | MRAM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 75% |
| Advances ODDS (%) | 3 days ago 83% | 13 days ago 79% |
| Declines ODDS (%) | 5 days ago 84% | 2 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 76% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AIP’s FA Score shows that 1 FA rating(s) are green while MRAM’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AIP’s TA Score shows that 3 TA indicator(s) are bullish while MRAM’s TA Score has 4 bullish TA indicator(s).
AIP (@Semiconductors) experienced а -14.68% price change this week, while MRAM (@Semiconductors) price change was -26.53% for the same time period.
The average weekly price growth across all stocks in the @Semiconductors industry was -18.46%. For the same industry, the average monthly price growth was -26.79%, and the average quarterly price growth was -46.04%.
AIP is expected to report earnings on Mar 03, 2027.
MRAM is expected to report earnings on Mar 03, 2027.
The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.
A.I.dvisor indicates that over the last year, AIP has been closely correlated with CEVA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if AIP jumps, then CEVA could also see price increases.
| Ticker / NAME | Correlation To AIP | 1D Price Change % | ||
|---|---|---|---|---|
| AIP | 100% | -12.74% | ||
| CEVA - AIP | 72% Closely correlated | -12.46% | ||
| ALGM - AIP | 70% Closely correlated | -10.06% | ||
| LSCC - AIP | 69% Closely correlated | -11.37% | ||
| AOSL - AIP | 69% Closely correlated | -15.32% | ||
| ARM - AIP | 68% Closely correlated | -14.09% | ||
More | ||||
A.I.dvisor indicates that over the last year, MRAM has been loosely correlated with AIP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if MRAM jumps, then AIP could also see price increases.
| Ticker / NAME | Correlation To MRAM | 1D Price Change % | ||
|---|---|---|---|---|
| MRAM | 100% | -16.36% | ||
| AIP - MRAM | 64% Loosely correlated | -12.74% | ||
| CEVA - MRAM | 62% Loosely correlated | -12.46% | ||
| AMD - MRAM | 61% Loosely correlated | -13.25% | ||
| GSIT - MRAM | 60% Loosely correlated | -10.32% | ||
| HIMX - MRAM | 60% Loosely correlated | -9.50% | ||
More | ||||